|HMGN -- USA Stock|| |
USD 0.01 0.00 0.00%
Principal Financial Officer, Principal Accounting Officer and Controller
Mrs. Catherine M. Davidson serves as Principal Accounting Officer, Controller of Hemagen Diadnostics, Inc. Mrs. Davidson was appointed Controller of Hemagen in April 2007. Prior to her appointment, Mrs. Davidson served as CFO of Pepco Building Services, Inc. On July 11, 2007, Catherine Davidson was appointed as the Companys Principal Financial Officer and Principal Accounting Officer. For the five years prior to joining Hemagen, Mrs. Davidson served as the Chief Financial Officer of Pepco Building Services, Inc., overseeing the finance and accounting functions of that company and its subsidiaries.
Age: 46 Executive Since 2013
The company has return on total asset (ROA)
of (10.27) %
which means that it has lost $10.27 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of (80.2) %
meaning that it created substantial loss on money invested by shareholders.
The company currently holds 5.03 M in liabilities. Hemagen Diagnostics has Current Ratio of 1.05 suggesting that it is not liquid enough and may have problems to pay out its financial obligations when they are due.
Hemagen Diagnostics, Inc., a biotechnology company, provides human and veterinary clinical diagnostic solutions worldwide. The company was founded in 1985 and is based in Columbia, Maryland. Hemagen Diagnostics operates under Biotechnology classification in USA and traded on OTC Market. It employs 15 people.Hemagen Diagnostics (HMGN) is traded on OTC Market in USA. It is located in 9033 Red Branch Road and employs 15 people.
Hemagen Diagnostics Leadership Team
Stock Performance Indicators